跳至主要内容
临床试验/NCT06209684
NCT06209684招募中不适用

Carbofix Pedicle Screw System: Randomized Clinical Trial to Evaluate the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases

Istituto Ortopedico Rizzoli2 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2022年4月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
118
试验地点
2
主要终点
Fusion rate

研究概览

简要总结

Previous clinical study carried out on cancer patients at IOR Spine Surgery (approved in October 2014). The carbon device is indicated in patients suffering from vertebral tumors who need stabilization and will then carry out radiotherapy, because carbon has a practically zero level of interference with ionizing radiation. Carbon also allows for better visualization of the implants on MRI/CT and X-ray. There are no studies in the literature analyzing the use of carbon fiber devices in lumbar degenerative pathologies.

118 patients suffering from degenerative spinal pathology requiring 1 or 2 levels of lumbar or lumbosacral fusion will be valutated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels;
  • Age greater than or equal to 18 years;
  • Ability to understand and sign the informed consent to the study and to follow the required follow-ups.

排除标准

  • Metabolic bone disease.
  • History of Paget's disease or other osteodystrophies, whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia.
  • Neoplastic disease.
  • History of mental disorder or current psychiatric treatment.
  • Pregnancy.
  • Immunodeficiency diseases.
  • Infectious bone disease (discitis, osteomyelitis)
  • Treatment with drugs that can interfere with bone metabolism
  • Inability to understand and sign the informed consent to the study and to follow the required follow-up visits.
  • Alcohol and/or drug abuse
  • Metal allergy
  • Participation in other studies on drugs or devices (within 30 days)

研究组 & 干预措施

Traditional

Active Comparator

Titanium implant for spinal surgery

干预措施: Titanium (Procedure)

Experimental

Experimental

CarboFix implant for spinal surgery

干预措施: Carbofix (Procedure)

结局指标

主要结局

Fusion rate

时间窗: through study completion, an average of 1 year

Fusion rate after 12 months as demonstrated by computed tomography scan (CT scan). The CT scan will be evaluated by Brantigan scale.

次要结局

  • Visual Analogue Scale(after 6 months)
  • EuroQoL-5D(after 6 months)
  • Short Form-12(after 6 months)
  • Classification system of surgical complications specific for spine(up to 12 months)
  • Oswestry Disability Index(after 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验